Idera Pharmaceuticals Inc. (NASDAQ:IDRA)‘s stock had its “outperform” rating reiterated by Wedbush in a research note issued on Friday. They currently have a $6.00 price objective on the stock. Wedbush’s price target suggests a potential upside of 250.88% from the stock’s previous close. Several other brokerages have also recently commented on IDRA. S&P Equity Research […]
